| |
| |
|
| Insider
Information: |
Turkel Catherine C. |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
90,162 |
|
|
Indirect Shares
|
805 |
|
|
| Direct
Value |
$182,644 |
|
|
|
Indirect Value
|
$1,658 |
|
|
| Total
Shares |
90,967 |
|
|
| Total
Value |
$184,302 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eledon Pharmaceuticals Ord Shs |
ELDN |
|
2019-05-21 |
88,662 |
2019-03-14 |
805 |
Premium* |
|
|
Lexaria Corp. |
LXRP |
Director |
2023-02-09 |
1,500 |
2023-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRP |
Lexaria Corp. |
Director |
– • – |
2023-02-09 |
4 |
B |
$2.84 |
$4,267 |
D/D |
1,500 |
1,500 |
2.31 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President |
• – – |
2019-05-21 |
4 |
S |
$1.91 |
$3,658 |
D/D |
(1,914) |
88,662 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President |
• – – |
2019-05-20 |
4 |
S |
$1.96 |
$14,953 |
D/D |
(7,623) |
90,576 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President |
• – – |
2019-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
98,199 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President |
• – – |
2018-09-12 |
4 |
B |
$5.02 |
$83,476 |
D/D |
16,632 |
78,199 |
2.74 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President |
• – – |
2018-09-11 |
4 |
B |
$4.56 |
$77,671 |
D/D |
17,048 |
61,567 |
2.74 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President |
• – – |
2018-09-05 |
4 |
B |
$3.97 |
$3,193 |
I/I |
805 |
805 |
1.91 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President |
• – – |
2018-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
44,519 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
Chief Development OfficerOffic |
• – – |
2017-05-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,408 |
|
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
Chief Development Officer |
• – – |
2017-05-10 |
4 |
B |
$9.99 |
$110,999 |
D/D |
11,111 |
24,519 |
2.74 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
